Jiri Pavlu is a Consultant Haematologist at Hammersmith Hospital and Honorary Clinical Senior Lecturer at Imperial College London. He graduated from the First Faculty of Medicine of Charles University in Prague in 1998. In completing this he was part of the research group of Professor Gordon-Smith at St.Georges Hospital Medical School in London and obtained his research degree in molecular haematology. He completed his specialist haematology training in London on the Royal Free and Hammersmith rotation.
He has developed a specialist interest in haematopoietic stem cell transplantation, particularly for leukaemia. He is the clinical lead for acute leukaemia and myelodysplastic syndromes and a stem cell transplant clinical and collection facility director. Together with Gill Brisley, clinical nurse specialist, and the transplant coordinators he runs relevant specialist haematology clinics at Hammersmith Hospital. He is a principal investigator and subinvestigator of various clinical trials, an active member of the European Group for Blood and Marrow Transplantation (EBMT) Acute leukaemia working party and also an accredited inspector for the Joint Accreditation Committee – International Society for Cellular Therapy (Europe) & EBMT.
Secretary: +44 (0) 2083838117, +44 (0) 2083835030
Fax: +44 (0) 2033133965
et al., 2019, Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT., J Hematol Oncol, Vol:12
et al., Complete remission with incomplete count recovery (CRi) prior to allogeneic HCT for acute myeloid leukaemia is associated with a high non-relapse mortality., Leukemia, ISSN:1476-5551
et al., 2019, Clinician Concepts of Cure in Adult Relapsed and Refractory Philadelphia-Negative B Cell Precursor Acute Lymphoblastic Leukemia: A Delphi Study, Advances in Therapy, Vol:36, ISSN:0741-238X, Pages:870-879
et al., 2019, Impact of route and adequacy of nutritional intake on outcomes of allogeneic haematopoietic cell transplantation for haematologic malignancies, Clinical Nutrition, Vol:38, ISSN:0261-5614, Pages:738-744
et al., 2019, Association of uric acid levels before start of conditioning with mortality after alloSCT - a prospective, non-interventional study of the EBMT transplant complication working party, 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), NATURE PUBLISHING GROUP, Pages:296-297, ISSN:0268-3369